Plan Group Financial’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$530K Buy
3,384
+667
+25% +$93.6K 0.1% 111
2026
Q2
$343K Buy
2,717
+673
+33% +$88.7K 0.07% 160
2026
Q1
$285K Buy
+2,044
New +$286K 0.07% 176

Other funds holding GILD

Plan Group Financial's GILD Position: Q3 2026 in Review

Plan Group Financial increased its Gilead Sciences (GILD) stake by 25% in Q3 2026, buying an estimated $93.6K and bringing the position to 3,384 shares worth $530K. The position accounts for 0.1% of the portfolio, ranked #111.

Plan Group Financial first reported a position in GILD in Q1 2026 and has held it in 3 quarters since. 2,354 funds tracked by Wall St. Rank hold GILD as of Q3 2026.

  • Plan Group Financial held 3,384 shares of Gilead Sciences worth $530K as of Q3 2026.
  • Plan Group Financial bought 667 Gilead Sciences shares in Q3 2026, an estimated $93.6K.
  • Gilead Sciences made up 0.1% of Plan Group Financial's portfolio in Q3 2026, its #111 holding.
  • Plan Group Financial first reported a position in Gilead Sciences in Q1 2026 and has held it in 3 quarters since.
  • 2,354 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.

Based on Plan Group Financial's 13F filing for Q3 2026, filed 22 Oct 2026.